Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Harrison

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Electrophoresis|May 29, 2000
Construction and evaluation of a capillary array DNA sequencer based on a micromachined sheath-flow cuvetteH J Crabtree, S J Bay, D F Lewis, et al.
British Journal of Cancer|May 3, 2012
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancerA H Sims, A J M Zweemer, Y Nagumo, et al.
Oncogene|February 1, 1994
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 geneC A Purdie, D J Harrison, A Peter, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Apoptosis in carcinogenesis: the role of p53A H Wyllie, P J Carder, A R Clarke, et al.
British Journal of Cancer|August 31, 1999
Apoptosis and carcinogenesisA H Wyllie, C O Bellamy, V J Bubb, et al.
Injury|January 18, 2006
Characterisation of orthopaedic trauma admitted to adult level 1 trauma centresD M Urquhart, E R Edwards, S E Graves, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndromeC E Patek, M H Little, S Fleming, et al.
ESMO Open|October 25, 2023
Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I studyS Phadnis, X Wang, N C Daw, et al.
ESMO Real World Data and Digital Oncology|April 22, 2026
Multi-site validation of an AI-based biomarker test for determining ER, PR, and HER2 status from H&E-stained breast cancer slidesF Ntelemis, S Wolf, C Bass, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Electrophoresis|May 29, 2000
Construction and evaluation of a capillary array DNA sequencer based on a micromachined sheath-flow cuvetteH J Crabtree, S J Bay, D F Lewis, et al.
British Journal of Cancer|May 3, 2012
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancerA H Sims, A J M Zweemer, Y Nagumo, et al.
Oncogene|February 1, 1994
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 geneC A Purdie, D J Harrison, A Peter, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Apoptosis in carcinogenesis: the role of p53A H Wyllie, P J Carder, A R Clarke, et al.
British Journal of Cancer|August 31, 1999
Apoptosis and carcinogenesisA H Wyllie, C O Bellamy, V J Bubb, et al.
Injury|January 18, 2006
Characterisation of orthopaedic trauma admitted to adult level 1 trauma centresD M Urquhart, E R Edwards, S E Graves, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndromeC E Patek, M H Little, S Fleming, et al.
ESMO Open|October 25, 2023
Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I studyS Phadnis, X Wang, N C Daw, et al.
ESMO Real World Data and Digital Oncology|April 22, 2026
Multi-site validation of an AI-based biomarker test for determining ER, PR, and HER2 status from H&E-stained breast cancer slidesF Ntelemis, S Wolf, C Bass, et al.
Pageof 22